Does Magnesium Increase or Decrease Estrogen?

Magnesium does not directly increase or decrease estrogen in any straightforward way. The relationship between the two runs in both directions, and the better-established direction is actually the reverse of what most people assume: estrogen influences magnesium status more than magnesium influences estrogen. Research consistently shows that estrogen drives magnesium into soft tissues and bone, which can lower the amount circulating in your blood, while magnesium levels and estrogen levels tend to move in opposite directions across the menstrual cycle and across life stages. Understanding this two-way interaction matters more than trying to pin down a simple “up or down” answer.

What Studies Actually Show About Magnesium and Estrogen Levels

One of the clearest findings in the research is an inverse correlation between magnesium and estrogen. In studies comparing premenopausal and menopausal women, magnesium levels in the blood tended to be higher when estrogen was lower, and lower when estrogen was higher. Menopausal women, who have significantly less estrogen, had higher circulating magnesium and calcium compared to premenopausal women. In premenopausal women measured during different phases of the cycle, magnesium levels inversely correlated with estrogen in both groups.¹

This inverse pattern does not mean that taking magnesium will push your estrogen down, or that low magnesium will cause estrogen to rise. Correlation is not causation here, and the reason for this seesaw pattern has more to do with what estrogen does to magnesium than the other way around. When estrogen levels climb, the hormone actively pulls magnesium out of your blood and into tissues like bone and muscle. That redistribution lowers the measurable magnesium in your serum, creating the appearance of an inverse relationship without magnesium having done anything to estrogen itself.

Estrogen’s Effect on Magnesium Is the Stronger Direction

The more established half of this relationship is how estrogen reshapes magnesium metabolism. Estrogen enhances magnesium uptake by soft tissues and bone, which researchers have suggested may partly explain why younger women with higher estrogen are naturally more resistant to heart disease and osteoporosis. When estrogen production drops after menopause, this protective shuttling of magnesium into tissues slows down, and the risk of those conditions rises.²

A large review of magnesium research across gender differences confirmed this pattern: estrogen positively influences magnesium absorption and retention, and when estrogen declines after menopause, the risk of magnesium deficiency increases.³ In other words, estrogen helps your body hold onto magnesium. Lose the estrogen, and you lose some of that magnesium-retaining ability.

But this mechanism has a catch. While estrogen helps tissues absorb magnesium, it can simultaneously lower the amount of magnesium in your blood. If your dietary magnesium intake is already on the low end, the estrogen-driven shift of magnesium into tissues can leave your blood levels uncomfortably depleted. The resulting rise in the calcium-to-magnesium ratio in the blood can favor clotting and vascular problems.² So estrogen’s effect on magnesium is a double-edged sword: beneficial for tissue health when magnesium intake is adequate, potentially harmful when it is not.

Oral Contraceptives and the Magnesium Drain

This dynamic becomes especially relevant for women taking estrogen-containing medications. Oral contraceptives deliver a steady dose of synthetic estrogen, and the same tissue-uptake mechanism kicks in. High estrogen levels from the pill stimulate magnesium utilization in tissues, which can push serum magnesium below normal in young women taking oral contraceptives.⁴ The magnesium is not lost from the body entirely; it is being relocated. But the drop in circulating magnesium can still produce symptoms like muscle cramps, irritability, and headaches that some women on hormonal birth control report.

A systematic analysis of the research on estrogen-containing drugs and magnesium concluded that estrogens exert a negative influence on magnesium and vitamin B6 metabolism. The authors argued that some of the side effects women experience on hormone replacement therapy and oral contraceptives could be reduced or eliminated by supplementing with magnesium and pyridoxine (vitamin B6) alongside the estrogen.⁵ This is not standard clinical practice everywhere, but the logic is sound: if estrogen depletes circulating magnesium, replacing that magnesium makes the estrogen therapy better tolerated.

What Happens at Menopause

When estrogen production drops sharply at menopause, the dynamic flips. Without estrogen pushing magnesium into tissues, serum magnesium levels tend to rise, but the protective tissue-level benefits of that magnesium redistribution disappear. This is one reason postmenopausal women face higher risks of osteoporosis and cardiovascular disease: the estrogen-magnesium partnership that was quietly protecting bones and blood vessels for decades stops working.

Research on postmenopausal women who used menopausal hormone therapy found that these women had significantly higher levels of magnesium (and zinc) compared to untreated postmenopausal women.⁶ A separate study found that women on hormone replacement therapy lost less magnesium and zinc through urine than untreated women, suggesting that restoring estrogen helps the body retain magnesium more efficiently.⁷

The bone health picture adds another layer. A study of nearly 200 postmenopausal women found that those with osteoporosis had significantly lower dietary intake of calcium, phosphorus, and magnesium compared to women without osteoporosis, and that magnesium intake correlated with bone mineral content.⁸ This does not mean magnesium alone prevents bone loss. But it does mean that after menopause, when estrogen is no longer doing the work of shuttling magnesium into bone tissue, adequate magnesium intake becomes more important, not less.

Magnesium Across the Menstrual Cycle

The interplay between magnesium and hormones is not static even within a single menstrual cycle. Estrogen and progesterone both fluctuate dramatically over the course of about 28 days, and those fluctuations drag magnesium along for the ride. Research measuring ionized magnesium and calcium throughout the menstrual cycle found that these mineral levels shift in response to changing sex hormone levels, with the calcium-to-magnesium ratio changing in ways that can affect blood vessels, nerve signaling, and cell communication.⁹

During the luteal phase, the stretch between ovulation and the start of your period, estrogen and progesterone are both elevated. Magnesium gets pulled into tissues more actively, and serum levels dip. For women whose magnesium intake is already marginal, or who happen to have an unusually high calcium-to-magnesium ratio, this dip may be enough to trigger the constellation of symptoms known as premenstrual syndrome: bloating, mood swings, cramping, headaches, and irritability.⁹

This is where the supplementation evidence becomes interesting. Trials have found that magnesium supplementation, either alone or combined with vitamin B6, can reduce the severity of PMS symptoms. The combination of magnesium plus B6 appeared to produce the most significant benefit in at least one study.¹⁰ The evidence here is still limited and the trials are generally small, but the biological logic is consistent: if hormone fluctuations are depleting your circulating magnesium during the luteal phase, replenishing it can soften the downstream effects.

The Neuroendocrine Side of Premenstrual Symptoms

The connection between magnesium and premenstrual distress goes deeper than just mineral levels. A narrative review of zinc, copper, and magnesium in premenstrual disorders identified two mechanisms that appear central to severe premenstrual symptoms: lower estrogen during the luteal phase reducing serotonin signaling, and reduced sensitivity to a neurosteroid called allopregnanolone throwing off the balance between excitatory and inhibitory brain chemicals.¹¹ Magnesium plays a known role in both of those signaling systems. It influences serotonin receptor activity and modulates the same inhibitory pathways that allopregnanolone acts on.

So when magnesium runs low during the luteal phase, the brain may lose a buffer against the mood and anxiety symptoms that falling estrogen and progesterone metabolites are already provoking. Supplementing magnesium does not raise estrogen. It does not fix the hormonal fluctuation. But it may shore up the neurochemical pathways that hormonal fluctuation disrupts, which is why women with PMS sometimes feel noticeably better on magnesium even though their hormone levels have not changed.

Why B6 Keeps Showing Up Alongside Magnesium

If you have looked into magnesium supplements for hormonal symptoms, you have probably noticed that vitamin B6 (pyridoxine) is almost always mentioned in the same breath. This is not just marketing. Estrogen-containing medications and high endogenous estrogen both appear to interfere with B6 metabolism, and B6 is itself involved in magnesium transport and utilization. A deficiency in one tends to worsen the status of the other.⁵

The practical upshot is that supplementing magnesium alone may not be as effective if you are also low in B6, and vice versa. For women taking oral contraceptives or hormone replacement therapy, both nutrients are under extra pressure from the estrogen load. The research pointing to magnesium-plus-B6 being more effective for PMS than magnesium alone fits neatly into this picture.¹⁰

Does Magnesium Help With Estrogen-Related Conditions?

Given everything above, the more useful question for most people is not whether magnesium raises or lowers estrogen, but whether magnesium supplementation can help with conditions influenced by estrogen. The answer varies by condition and by how strong the evidence is.

For PMS, the evidence is modest but positive. Small trials and open-label studies suggest benefit, especially when combined with B6. For menopausal bone loss, adequate dietary magnesium is clearly associated with better bone mineral content, and magnesium supplementation may be a reasonable part of a bone-health strategy, though it is not a substitute for other interventions.⁸ For cardiovascular protection, the theoretical basis is strong: estrogen’s loss after menopause removes a mechanism that was keeping magnesium in the right tissues, and supplementing magnesium could partially compensate.² But large-scale trials specifically testing magnesium for cardiovascular outcomes in postmenopausal women are lacking.

For women on hormone therapy, the case for co-supplementing magnesium is relatively straightforward. Estrogen therapy helps the body retain magnesium, but it also increases tissue demand. Making sure your magnesium intake is adequate while on estrogen-containing medications is a reasonable precaution that the research supports, even if your doctor does not routinely mention it.

Pregnancy and Magnesium Deficiency Risk

Pregnancy involves some of the highest sustained estrogen levels a woman’s body will ever produce. By the third trimester, estrogen levels are many times higher than during a normal menstrual cycle. This massive estrogen surge drives magnesium into tissues aggressively, and magnesium deficiency during pregnancy is well documented. An analysis of a large real-world dataset found that magnesium deficiency is more common in women than men overall, and that estrogen’s stimulation of tissue magnesium utilization partially explains this disparity.¹²

During pregnancy, the stakes of magnesium depletion are higher. Eclampsia and preeclampsia, two serious complications involving dangerously high blood pressure, have long been treated with intravenous magnesium sulfate. The connection between low magnesium, high estrogen, and the vascular problems of pregnancy is one of the oldest threads in this research area. Adequate magnesium during pregnancy is important not because it changes estrogen levels, but because the high estrogen environment makes the body consume magnesium faster than many women’s diets can replenish it.

SHBG and the Question of Hormone Bioavailability

One mechanism that sometimes comes up in online discussions is whether magnesium affects sex hormone-binding globulin, the protein that binds to sex hormones in the blood and controls how much of them is “free” and active. Research using a novel chromatography approach found that magnesium can slightly alter the binding affinity between testosterone and SHBG, but the effect was small because the number of magnesium ions linked to the binding process is low.¹³ The same research group noted the potential for studying SHBG interactions with estrogens and phytoestrogens, but that work has not yet produced clear findings.

So the idea that magnesium frees up estrogen by knocking it off SHBG, a claim you sometimes see in supplement marketing, is largely unsupported. The magnesium-SHBG interaction is real but appears to be too small to meaningfully change how much free estrogen is circulating. If magnesium affects estrogen-related symptoms, the mechanism almost certainly runs through the mineral and neurotransmitter pathways discussed earlier, not through SHBG manipulation.

Who Is Most Likely to Be Magnesium Deficient

Because estrogen status affects magnesium retention, certain groups of women are at higher risk of running low. Postmenopausal women who are not on hormone therapy lose estrogen’s magnesium-retaining effect and often have lower dietary intake of magnesium as well.³ Women on oral contraceptives face the opposite problem: their estrogen is high, driving magnesium into tissues and potentially lowering blood levels.¹² Pregnant women in the second and third trimesters are under the most extreme version of this demand. And women with severe PMS may be more susceptible to the cyclical magnesium dips that hormonal fluctuations create, even if their average intake is technically adequate.

None of these groups will fix their hormonal issues by taking magnesium. But all of them may feel meaningfully better by not being deficient in it, because magnesium depletion amplifies many of the same symptoms that hormone shifts produce: muscle tension, sleep disruption, mood instability, and cardiovascular stress. The mineral is not a hormone modulator. It is a cofactor in hundreds of enzymatic reactions, and when its levels swing because of hormonal changes, the body notices.

1
Clinical Obstetrics, Gynecology and Reproductive Medicine. Menopausal hot flashes: The role of magnesium and select endocrine factors
2
PubMed. Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome
3
MDPI Nutrients. Magnesium: Exploring Gender Differences in Its Health Impact and Dietary Intake
4
PubMed Central. Risk factors and comorbidities associated with magnesium deficiency in pregnant women and women with hormone-related conditions: analysis of a large real-world dataset
5
Obstetrics, Gynecology and Reproduction. Systematic analysis of fundamental and clinical research, as justification for the use of estrogen-containing drugs with the preparations of magnesium and pyridoxine
6
PubMed. Effect of menopausal hormone therapy on the levels of magnesium, zinc, lead and cadmium in post-menopausal women
7
PubMed. Trace mineral status in post menopausal women: impact of hormonal replacement therapy
8
PubMed. Calcium, phosphorus and magnesium intakes correlate with bone mineral content in postmenopausal women
9
PubMed. Sex steroid hormones modulate serum ionized magnesium and calcium levels throughout the menstrual cycle in women
10
Open Journal of Obstetrics and Gynecology. Magnesium in Women’s Health and Gynecology
11
SpringerLink / Pharmacological Reports. Zinc, copper, and magnesium in premenstrual disorders: a narrative review
12
PubMed Central. Risk factors and comorbidities associated with magnesium deficiency in pregnant women and women with hormone-related conditions
13
PubMed Central. Magnesium effect on testosterone-SHBG association studied by a novel molecular chromatography approach